Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Van Lancker

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Biometrics|April 29, 2026
Discussion on ''Nonparanormal Adjusted Marginal Inference'' by Susanne Dandl and Torsten HothornKelly Van Lancker, Oliver Dukes
Clinical Trials (London, England)|June 3, 2024
Response to Harrell's commentaryKelly Van Lancker, Frank Bretz, Oliver Dukes
Statistics in Medicine|May 12, 2021
Principled selection of baseline covariates to account for censoring in randomized trials with a survival endpointKelly Van Lancker, Oliver Dukes, Stijn Vansteelandt
Pharmaceutical Statistics|April 6, 2020
Improving interim decisions in randomized trials by exploiting information on short-term endpoints and prognostic baseline covariatesKelly Van Lancker, An Vandebosch, Stijn Vansteelandt
Biometrical Journal. Biometrische Zeitschrift|July 11, 2021
Efficient, doubly robust estimation of the effect of dose switching for switchers in a randomized clinical trialKelly Van Lancker, An Vandebosch, Stijn Vansteelandt
Clinical Trials (London, England)|June 3, 2024
Covariate adjustment in randomized controlled trials: General concepts and practical considerationsKelly Van Lancker, Frank Bretz, Oliver Dukes
Biometrics|June 23, 2023
Ensuring valid inference for Cox hazard ratios after variable selectionKelly Van Lancker, Oliver Dukes, Stijn Vansteelandt
Biometrics|March 10, 2025
Combining covariate adjustment with group sequential, information-adaptive designs to improve randomized trial efficiencyKelly Van Lancker, Joshua F Betz, Michael Rosenblum
Statistics in Medicine|November 17, 2022
Estimands in heath technology assessment: a causal inference perspectiveKelly Van Lancker, Tat-Thang Vo, Mouna Akacha
Clinical Trials (London, England)|May 9, 2026
Adaptive trial design and interim decision-making using incomplete longitudinal measurements: Methods and application to myasthenia gravisKush Kapur, Fien Gistelinck, An Vandebosch, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biometrics|April 29, 2026
Discussion on ''Nonparanormal Adjusted Marginal Inference'' by Susanne Dandl and Torsten HothornKelly Van Lancker, Oliver Dukes
Clinical Trials (London, England)|June 3, 2024
Response to Harrell's commentaryKelly Van Lancker, Frank Bretz, Oliver Dukes
Statistics in Medicine|May 12, 2021
Principled selection of baseline covariates to account for censoring in randomized trials with a survival endpointKelly Van Lancker, Oliver Dukes, Stijn Vansteelandt
Pharmaceutical Statistics|April 6, 2020
Improving interim decisions in randomized trials by exploiting information on short-term endpoints and prognostic baseline covariatesKelly Van Lancker, An Vandebosch, Stijn Vansteelandt
Biometrical Journal. Biometrische Zeitschrift|July 11, 2021
Efficient, doubly robust estimation of the effect of dose switching for switchers in a randomized clinical trialKelly Van Lancker, An Vandebosch, Stijn Vansteelandt
Clinical Trials (London, England)|June 3, 2024
Covariate adjustment in randomized controlled trials: General concepts and practical considerationsKelly Van Lancker, Frank Bretz, Oliver Dukes
Biometrics|June 23, 2023
Ensuring valid inference for Cox hazard ratios after variable selectionKelly Van Lancker, Oliver Dukes, Stijn Vansteelandt
Biometrics|March 10, 2025
Combining covariate adjustment with group sequential, information-adaptive designs to improve randomized trial efficiencyKelly Van Lancker, Joshua F Betz, Michael Rosenblum
Statistics in Medicine|November 17, 2022
Estimands in heath technology assessment: a causal inference perspectiveKelly Van Lancker, Tat-Thang Vo, Mouna Akacha
Clinical Trials (London, England)|May 9, 2026
Adaptive trial design and interim decision-making using incomplete longitudinal measurements: Methods and application to myasthenia gravisKush Kapur, Fien Gistelinck, An Vandebosch, et al.
Pageof 2